knowledge -WSS

knowledge

author：entertainment 2025-08-12 11:29:14 - browse：4437

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Cancer drug shortages should be causing more outrage
Next article： AdventHealth escalates lawsuit against insurance vendor Multiplan

WSS

Why Talkspace is targeting Medicare, a tricky market

Feng Zhang, Grail founder join forces on new gene editing startup

Chronically ill young patients struggle to find fertility info

Lack of health data on LGBTQ+ people has serious consequences

A single drug, study failures leave Anavex with nothing but cash

Morgan Health, with ambitious aims, wants you to know it’s still here

hotspot

knowledge

explore

Medical records are filled with copy

U.K. sequencing study surfaces new findings about tumor DNA

The cancer drug shortage isn’t new — and neither are the solutions

White House finalizes ITC's import ban of latest Apple Watches

Novavax promises a turnaround & Lilly roils the obesity market

Streamlined flu vaccines recommended by FDA advisory panel

ChatGPT in medicine: STAT answers readers' burning questions

Ahead of JPM, here's who's profiting most in health care

Affirmative action in medical school literally saved lives

Immune cells and nerve overgrowth may explain recurring UTI pain

hotspot

3 medical device trends to watch in 2024

Ancient Greek ideas underpin modern concepts of pregnancy

Medicare drug price negotiation hearing pits pharma v Biden admin

Immune cells and nerve overgrowth may explain recurring UTI pain

Goldman Sachs launches $650M fund for life science investments

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

hotspot

focus

leisure time

entertainment